Ad is loading...
JSLCX
Price
$11.90
Change
-$0.02 (-0.17%)
Updated
Nov 15 closing price
PACAX
Price
$10.92
Change
-$0.06 (-0.55%)
Updated
Nov 15 closing price
Ad is loading...

JSLCX vs PACAX

Header iconJSLCX vs PACAX Comparison
Open Charts JSLCX vs PACAXBanner chart's image
JHancock Multimanager Lifestyle Cnsrv R4
Price$11.90
Change-$0.02 (-0.17%)
VolumeN/A
CapitalizationN/A
Putnam Dynamic Asset Allocation Cnsrv A
Price$10.92
Change-$0.06 (-0.55%)
VolumeN/A
CapitalizationN/A
JSLCX vs PACAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JSLCX vs. PACAX commentary
Nov 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSLCX is a Hold and PACAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
JSLCX has more cash in the bank: 1.65B vs. PACAX (576M). JSLCX pays higher dividends than PACAX: JSLCX (3.69) vs PACAX (2.18). JSLCX was incepted earlier than PACAX: JSLCX (19 years) vs PACAX (31 years). PACAX is a more actively managed with annual turnover of: 456.00 vs. JSLCX (15.00). JSLCX (0) and PACAX (0) have matching initial minimum investment requirements. PACAX annual gain was more profitable for investors over the last year : 16.76 vs. JSLCX (11.81). PACAX return over 5 years is better than : 11.40 vs. JSLCX (7.68).
JSLCXPACAXJSLCX / PACAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years31 years-
Gain YTD6.26710.12362%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.65B576M287%
Annual Yield % from dividends3.692.18169%
Returns for 1 year11.8116.7670%
Returns for 3 years-4.11-2.74150%
Returns for 5 years7.6811.4067%
Returns for 10 years14.8215.3996%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GPGCX16.980.11
+0.65%
Grandeur Peak Global Contrarian Instl
JHLVX62.38N/A
N/A
JHancock Fundamental Large Cap Core C
FIUSX38.16N/A
N/A
Delaware Opportunity A
NSFEX11.43-0.04
-0.35%
Natixis Target Retirement 2025 N
ETNHX34.80-0.82
-2.30%
Eventide Healthcare & Life Sciences N